comparemela.com

Latest Breaking News On - Antibody dependent cellular phagocytosis - Page 20 : comparemela.com

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR21

DGAP-News: MorphoSys AG / Key word(s): AgreementMorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 14.06.2022 / 22:01 The issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, South San Francisco, United States, June.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.